JPS626712B2 - - Google Patents
Info
- Publication number
- JPS626712B2 JPS626712B2 JP55031776A JP3177680A JPS626712B2 JP S626712 B2 JPS626712 B2 JP S626712B2 JP 55031776 A JP55031776 A JP 55031776A JP 3177680 A JP3177680 A JP 3177680A JP S626712 B2 JPS626712 B2 JP S626712B2
- Authority
- JP
- Japan
- Prior art keywords
- fluorouracil
- amino
- group
- reaction
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明はアミノ―5―フルオロウラシル誘導体
及びその製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to amino-5-fluorouracil derivatives and methods for producing the same.
本発明のアミノ―5―フルオロウラシル誘導体
は新規化合物であり、一般式
〔式中R1は低級アシルアミノ基又はアリール
スルホニルアミノ基、R2は水素又はアリールス
ルホニルアミノ基を示す〕で表わされる。 The amino-5-fluorouracil derivative of the present invention is a new compound, and has the general formula [In the formula, R 1 represents a lower acylamino group or an arylsulfonylamino group, and R 2 represents hydrogen or an arylsulfonylamino group].
本発明において低級アシルアミノ基としては、
アセチルアミノ基、プロピオニルアミノ基、ブチ
リルアミノ基、ヘキサノイルアミノ基等の炭素数
2〜6のアシルアミノ基が、またアリールスルホ
ニルアミノ基としてはベンゼンスルホニルアミノ
基、p―トルエンスルホニルアミノ基、ジ―p―
トルエンスルホニルアミノ基等が例示される。 In the present invention, lower acylamino groups include:
Acylamino groups having 2 to 6 carbon atoms such as acetylamino group, propionylamino group, butyrylamino group, hexanoylamino group, etc., and arylsulfonylamino groups such as benzenesulfonylamino group, p-toluenesulfonylamino group, di-p-
Examples include toluenesulfonylamino group.
本発明の化合物は5―フルオロウラシルの新規
誘導体であり、例えば抗腫瘍剤として有用であ
る。 The compounds of the present invention are novel derivatives of 5-fluorouracil and are useful, for example, as antitumor agents.
本発明の化合物は例えば以下に示す方法によつ
て製造することができる。 The compound of the present invention can be produced, for example, by the method shown below.
〔式中Rは水素又はアミノ基、R3は低級アシ
ル基またはアリールスルホニル基、Xはハロゲン
原子を示し、また(R4CO)2Oは脂肪族カルボン
酸無水物を示す。R1,R2は前記に同じ。〕
すなわち、まず5―フルオロウラシルとハイド
ロキシルアミン―O―スルホン酸あるいはO―メ
シチレンスルホニルハイドロキシルアミン等のア
ミノ化剤とを反応させて、3―アミノ―5―フル
オロウラシル及び/又は1,3―ジアミノ―5―
フルオロウラシルより成るN―アミノ―5―フル
オロウラシルを得ることができる。 [In the formula, R represents hydrogen or an amino group, R 3 represents a lower acyl group or an arylsulfonyl group, X represents a halogen atom, and (R 4 CO) 2 O represents an aliphatic carboxylic acid anhydride. R 1 and R 2 are the same as above. ] That is, first, 5-fluorouracil and an aminating agent such as hydroxylamine-O-sulfonic acid or O-mesitylenesulfonylhydroxylamine are reacted to form 3-amino-5-fluorouracil and/or 1,3-diamino-5. ―
N-amino-5-fluorouracil consisting of fluorouracil can be obtained.
上記アミノ化反応は5―フルオロウラシル1モ
ルに対してアミノ化剤を約1〜10モル、好ましく
は約1〜5モルを用いる。反応溶媒としては、本
反応に関与しないものであれば特に限定されない
が、例えばクロロホルム、ジクロロメタン、ジク
ロロエタン、ニトロメタン、ジオキサン等の非プ
ロトン性極性溶媒、水あるいは炭酸ナトリウム―
炭酸水素ナトリウムによる緩衝液等を用いること
もできる。反応は通常約0〜100℃の温度で行う
が、反応を有機溶媒中で行う時は約0〜30℃、水
中で行う時は約60〜80℃で行うのが好ましい。反
応時間は約1〜48時間であるが、通常約2〜5時
間で反応は終了する。 In the above amination reaction, the aminating agent is used in an amount of about 1 to 10 moles, preferably about 1 to 5 moles, per mole of 5-fluorouracil. The reaction solvent is not particularly limited as long as it does not participate in this reaction, but examples include aprotic polar solvents such as chloroform, dichloromethane, dichloroethane, nitromethane, and dioxane, water, and sodium carbonate.
A buffer such as sodium hydrogen carbonate may also be used. The reaction is usually carried out at a temperature of about 0 to 100°C, preferably about 0 to 30°C when carried out in an organic solvent, and preferably about 60 to 80°C when carried out in water. The reaction time is about 1 to 48 hours, but the reaction is usually completed in about 2 to 5 hours.
N―アミノ―5―フルオロウラシルと低級アシ
ルハライド、アリールスルホニルハライド又は脂
肪族カルボン酸無水物等との反応はN―アミノ―
5―フルオロウラシルを単離した後行うこともで
きるが単離せずに行うこともできる。 The reaction between N-amino-5-fluorouracil and lower acyl halide, arylsulfonyl halide, or aliphatic carboxylic acid anhydride is N-amino-5-fluorouracil.
This can be carried out after isolating 5-fluorouracil, but it can also be carried out without isolation.
反応はN―アミノ―5―フルオロウラシル1モ
ルに対して低級アシルハライド、アリールスルホ
ニルハライドあるいは脂肪族カルボン酸無水物を
約1〜10モル、好ましくは約1〜5モルを用いる
のが良い。また脱ハロゲン化水素剤として、トリ
エチルアミン、トリメチルアミン、ピリジン、ピ
コリン等の三級アミンを、低級アシルハライド、
アリールスルホニルハライドの1モルに対して通
常約1モル以上を使用するのが好ましく、またピ
リジン、ピコリン等を溶媒として使用することも
できる。脂肪族カルボン酸無水物を反応させる場
合には三級アミンは添加してもしなくとも良い。
溶媒は反応に関与しないものであれば特に限定さ
れないが、クロロホルム、ジクロロメタン、ジク
ロロエタン、ニトロメタン、ジオキサン、ジエチ
ルエーテル、アセトン、ジメチルホルムアミド、
ジメチルスルホキシド等またはピリジン、ピコリ
ン等のアミン類などがあげられる。 In the reaction, lower acyl halide, arylsulfonyl halide or aliphatic carboxylic acid anhydride is preferably used in an amount of about 1 to 10 moles, preferably about 1 to 5 moles, per mole of N-amino-5-fluorouracil. In addition, as dehydrohalogenation agents, tertiary amines such as triethylamine, trimethylamine, pyridine, and picoline, lower acyl halides,
It is generally preferable to use about 1 mole or more per mole of arylsulfonyl halide, and pyridine, picoline, etc. can also be used as a solvent. When reacting an aliphatic carboxylic acid anhydride, a tertiary amine may or may not be added.
The solvent is not particularly limited as long as it does not participate in the reaction, but examples include chloroform, dichloromethane, dichloroethane, nitromethane, dioxane, diethyl ether, acetone, dimethylformamide,
Examples include dimethyl sulfoxide and amines such as pyridine and picoline.
反応は通常約0〜100℃の温度で行うが、低級
アシルハライド、アリールスルホニルハライドの
反応では約0〜30℃、脂肪族カルボン酸無水物の
反応では約60〜80℃で行うのが好ましい。 The reaction is usually carried out at a temperature of about 0 to 100°C, preferably about 0 to 30°C for reactions of lower acyl halides and arylsulfonyl halides, and about 60 to 80°C for reactions of aliphatic carboxylic anhydrides.
以下に実施例を挙げて本発明を具体的に説明す
る。 The present invention will be specifically described below with reference to Examples.
実施例 1
3―アミノ―5―フルオロウラシル1g
(0.0069モル)をジオキサン20mlに加温下溶解
し、水2ml、無水酪酸4.4g(0.028モル)を加え
て80℃で12時間撹拌する。Example 1 3-amino-5-fluorouracil 1 g
(0.0069 mol) was dissolved in 20 ml of dioxane under heating, 2 ml of water and 4.4 g (0.028 mol) of butyric anhydride were added, and the mixture was stirred at 80°C for 12 hours.
反応液を減圧濃縮し、残渣のシリカゲルカラム
クロマトグフイー(展開溶媒、クロロホルム:エ
タノール=4:1)を行い、生成物を分離する。
溶出液を分取して減圧濃縮し、残渣をエタノール
から再結晶して3―ブチリルアミノ―5―フルオ
ロウラシルの結晶0.7g(収率47%)を得る。 The reaction solution is concentrated under reduced pressure, and the residue is subjected to silica gel column chromatography (developing solvent: chloroform:ethanol = 4:1) to separate the product.
The eluate is separated and concentrated under reduced pressure, and the residue is recrystallized from ethanol to obtain 0.7 g of crystals of 3-butyrylamino-5-fluorouracil (yield: 47%).
分解点185〜7℃
元素分析 C8H10N3O3Fとして
計算値(%):C,44.65;H,4.68;
;N,19.53
実測値(%):C,44.59;H,4.78;
;N,19.44
この後の溶出液を分取して減圧濃縮し、油状の
3―アミノ―1―ブチリル−5―フルオロウラシ
ルを得た。Decomposition point 185-7℃ Elemental analysis As C 8 H 10 N 3 O 3 F Calculated value (%): C, 44.65; H, 4.68; ; N, 19.53 Actual value (%): C, 44.59; H, 4.78; ;N, 19.44 The eluate was fractionated and concentrated under reduced pressure to obtain oily 3-amino-1-butyryl-5-fluorouracil.
実施例 2
5―フルオロウラシル9g(0.069モル)を2N
―水酸化ナトリウム340mlに溶解し、ハイドロキ
シルアミン―O―スルホン酸38g(0.34モル)を
冷水170mlに溶解して滴下する。次いで反応液を
80℃で4時間加熱撹拌する。4時問後反応液を塩
酸で中和した後減圧濃縮し、残渣にエタノールを
加えて、加温下抽出する。エタノール溶液を濃縮
後、残渣を乾燥し、次いでこれをピリジン100ml
に溶解した後、p―トルエンスルホニルクロライ
ド7.2g(0.038モル)を加えて室温で一晩撹拌す
る。反応液を濃縮した後、残渣を氷水中に激しく
撹拌しながら加え析出した沈でんを取する。乾
燥後シリカゲルカラムクロマトグラフイー(展開
溶媒、クロロホルム:エタノール=4:1)を行
い生成物を分離する。Example 2 9 g (0.069 mol) of 5-fluorouracil in 2N
-Dissolve in 340 ml of sodium hydroxide, and add dropwise 38 g (0.34 mol) of hydroxylamine-O-sulfonic acid dissolved in 170 ml of cold water. Then add the reaction solution
Heat and stir at 80°C for 4 hours. After 4 hours, the reaction solution was neutralized with hydrochloric acid, concentrated under reduced pressure, ethanol was added to the residue, and extracted under heating. After concentrating the ethanol solution, dry the residue, and then add 100ml of pyridine.
After dissolving in the solution, 7.2 g (0.038 mol) of p-toluenesulfonyl chloride was added and stirred overnight at room temperature. After concentrating the reaction solution, the residue was added to ice water with vigorous stirring to remove the precipitate. After drying, silica gel column chromatography (developing solvent, chloroform:ethanol = 4:1) is performed to separate the product.
溶出液を分取して減圧濃縮し、残渣を乾燥して
粉末状の3―(ジ―p―トルエンスルホニル)ア
ミノ―5―フルオロウラシル1.7g(収率5.4%)
を得た。 The eluate was separated and concentrated under reduced pressure, and the residue was dried to obtain 1.7 g of powdered 3-(di-p-toluenesulfonyl)amino-5-fluorouracil (yield 5.4%).
I got it.
分解点98℃
元素分析 C18H16N3O6S2Fとして
計算値(%):C,47.68;H,3.56;
N,9.27
実測値(%):C,47.64;H,3.66;
N,9.25
この後の溶出液を分取して減圧濃縮し、残渣を
エタノールから再結晶して一番晶に1,3―ジ―
p―トルエンスルホニルアミノ―5―フルオロウ
ラシルの結晶1.9g(収率5.9%)を得た。Decomposition point 98℃ Elemental analysis C 18 H 16 N 3 O 6 S 2 Calculated value (%): C, 47.68; H, 3.56; N, 9.27 Actual value (%): C, 47.64; H, 3.66; N , 9.25 The eluate was collected and concentrated under reduced pressure, and the residue was recrystallized from ethanol to give the first crystalline 1,3-di-
1.9 g (yield 5.9%) of crystals of p-toluenesulfonylamino-5-fluorouracil were obtained.
融点224〜227℃
元素分析 C18H17N4O6S2Fとして
計算値(%):C,46.15;H,3.66;
N,11.96
実測値(%):C,46.13;H,3.58;
N,12.05
1,3―ジ―p―トルエンスルホニルアミノ―
5―フルオロウラシルを得た後、液を濃縮し、
残渣をエタノールから再結晶して3―p―トルエ
ンスルホニルアミノ―5―フルオロウラシルの結
晶2.9g(収率14%)を得た。Melting point 224-227°C Elemental analysis As C 18 H 17 N 4 O 6 S 2 F Calculated value (%): C, 46.15; H, 3.66; N, 11.96 Actual value (%): C, 46.13; H, 3.58; N, 12.05 1,3-di-p-toluenesulfonylamino-
After obtaining 5-fluorouracil, the liquid was concentrated,
The residue was recrystallized from ethanol to obtain 2.9 g (yield: 14%) of 3-p-toluenesulfonylamino-5-fluorouracil crystals.
分解点228℃
元素分析 C11H10N3O4SFとして
計算値(%):C,44.15;H,3.37;
N,14.04
実測値(%):C,44.01;H,3.23;
N,13.92
実施例 3
5―フルオロウラシル13g(0.1モル)を1M炭
酸ナトリウム―炭酸水素ナトリウム(PH9)300
mlに溶解し、ハイドロキシルアミン―O―スルホ
ン酸15g(0.13モル)を加えた後80℃で2時間撹
拌する。2時間後反応液を減圧濃縮し、残渣にエ
タノールを加えて加温下抽出する。エタノール抽
出液を活性炭処理した後、濃縮し残渣を乾燥す
る。次いでこれをピリジン140mlに溶解した後p
―トルエンスルホニルクロライド10.3g(0.054
モル)を加えて一晩撹拌する。反応液を濃縮した
後残渣を氷水に激しく撹拌しながらあけ析出した
沈でんを取する。この沈でんをエタノールから
再結晶して、3―p―トルエンスルホニルアミノ
―5―フルオロウラシルの結晶9.7g(収率32
%)を得た。分解点228℃〜。Decomposition point 228℃ Elemental analysis C 11 H 10 N 3 O 4 As SF Calculated value (%): C, 44.15; H, 3.37; N, 14.04 Actual value (%): C, 44.01; H, 3.23; N, 13.92 Example 3 13 g (0.1 mol) of 5-fluorouracil was added to 1M sodium carbonate-sodium hydrogen carbonate (PH9) 300
ml, add 15 g (0.13 mol) of hydroxylamine-O-sulfonic acid, and stir at 80°C for 2 hours. After 2 hours, the reaction solution was concentrated under reduced pressure, and ethanol was added to the residue for extraction under heating. After treating the ethanol extract with activated carbon, it is concentrated and the residue is dried. Next, after dissolving this in 140 ml of pyridine,
-Toluenesulfonyl chloride 10.3g (0.054
mol) and stir overnight. After concentrating the reaction solution, pour the residue into ice water with vigorous stirring to remove the precipitate. This precipitate was recrystallized from ethanol to give 9.7 g of crystals of 3-p-toluenesulfonylamino-5-fluorouracil (yield: 32
%) was obtained. Decomposition point: 228℃~
Claims (1)
スルホニルアミノ基、R2は水素又はアリールス
ルホニルアミノ基を示す〕で表わされるアミノ―
5―フルオロウラシル誘導体。 2 5―フルオロウラシルとアミノ化剤とを反応
させて得られる反応生成物に、次いで低級アシル
ハライド、脂肪族カルボン酸無水物、アリールス
ルホニルハライドから選ばれた1種を反応させる
ことを特徴とする一般式 〔式中R1は低級アシルアミノ基又はアリール
スルホニルアミノ基、R2は水素又はアリールス
ルホニルアミノ基を示す〕で表わされるアミノ―
5―フルオロウラシル誘導体の製造法。 3 一般式 〔Rは水素又はアミノ基〕に低級アシルハライ
ド、脂肪族カルボン酸無水物、アリールスルホニ
ルハライドから選ばれた1種を反応させることを
特徴とする一般式 〔式中R1は低級アシルアミノ基又はアリール
スルホニルアミノ基、R2は水素又はアリールス
ルホニルアミノ基を示す〕で表わされるアミノ―
5―フルオロウラシル誘導体の製造法。[Claims] 1. General formula Amino- _
5-Fluorouracil derivative. 2. A general method characterized in that the reaction product obtained by reacting 5-fluorouracil and an aminating agent is then reacted with one selected from lower acyl halides, aliphatic carboxylic acid anhydrides, and arylsulfonyl halides. formula Amino- _
A method for producing a 5-fluorouracil derivative. 3 General formula A general formula characterized by reacting [R is hydrogen or an amino group] with one selected from lower acyl halides, aliphatic carboxylic acid anhydrides, and arylsulfonyl halides. Amino- _
A method for producing a 5-fluorouracil derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3177680A JPS56128769A (en) | 1980-03-12 | 1980-03-12 | Amino-5-fluorouracil derivative and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3177680A JPS56128769A (en) | 1980-03-12 | 1980-03-12 | Amino-5-fluorouracil derivative and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56128769A JPS56128769A (en) | 1981-10-08 |
| JPS626712B2 true JPS626712B2 (en) | 1987-02-13 |
Family
ID=12340447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3177680A Granted JPS56128769A (en) | 1980-03-12 | 1980-03-12 | Amino-5-fluorouracil derivative and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56128769A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0266811U (en) * | 1988-11-09 | 1990-05-21 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006135312A1 (en) * | 2005-06-17 | 2006-12-21 | Astrazeneca Ab | Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
-
1980
- 1980-03-12 JP JP3177680A patent/JPS56128769A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0266811U (en) * | 1988-11-09 | 1990-05-21 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56128769A (en) | 1981-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108947919B (en) | A novel preparation method of anti-gout drug Lesinurad and its key intermediate | |
| JPS631952B2 (en) | ||
| JPS626713B2 (en) | ||
| JPS61186381A (en) | Manufacture of ergoline derivative | |
| JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
| PL187648B1 (en) | Method of obtaining a derivative of deoxyuridine | |
| AU2004296242A1 (en) | Improved synthesis of 2-substituted adenosines | |
| JPS59155400A (en) | Improved preparation of c-amp acyl derivative | |
| JPH0543603A (en) | (galactopyranosyl)cyclomaltheptaose, preparation thereof, and intermediate therefor | |
| JP3074665B2 (en) | Method for producing novel hydrazone compounds and triazole compounds | |
| JP3051213B2 (en) | Maltooligosaccharide derivatives, their synthetic intermediates and their production | |
| JPH0372493A (en) | Production of 2'-o-substituted-adenosine-3',5'-cyclic phosphoric acid or its salt | |
| JPS6140669B2 (en) | ||
| JPH0318620B2 (en) | ||
| JPH0527617B2 (en) | ||
| JPS5946260A (en) | Benzoic acid derivative | |
| JPH02256659A (en) | Diacylamide compound and production of amide | |
| JPH07116213B2 (en) | Novel N-6,2'-O-disubstituted-adenosine-3 ', 5'-cyclic phosphate and process for producing the same | |
| JPH051093A (en) | Method for succinylation of nucleosides | |
| JPH0443076B2 (en) | ||
| JPH07285921A (en) | Method for producing 2-amino-N- (β-hydroxyphenethyl) acetamide derivative | |
| JPS6356218B2 (en) | ||
| JPS6051184A (en) | N-cyanoiminothiazolidine derivative and its preparation | |
| JPH027318B2 (en) | ||
| JPS5832859A (en) | N,n-dimethylcarbamic acid benzyl ester derivative |